Vitamin D receptor gene polymorphisms and multiple myeloma: a meta-analysis.
Gene polymorphism
Meta-analysis
Multiple myeloma
Vitamin D receptor
Journal
Clinical and experimental medicine
ISSN: 1591-9528
Titre abrégé: Clin Exp Med
Pays: Italy
ID NLM: 100973405
Informations de publication
Date de publication:
04 Jun 2024
04 Jun 2024
Historique:
received:
19
06
2023
accepted:
18
05
2024
medline:
4
6
2024
pubmed:
4
6
2024
entrez:
4
6
2024
Statut:
epublish
Résumé
Vitamin D acts through the vitamin D receptor (VDR), and vitamin D level decreases in multiple myeloma (MM) patients. Single nucleotide polymorphisms in VDR alter its functions to affect the vitamin D status. This raises the question of whether VDR gene polymorphisms are associated with MM risk, which has been investigated in case‒control studies, but the results have been inconsistent. This meta-analysis aimed to investigate the relationship between VDR gene polymorphisms and MM risk. The PubMed, Web of Science, Medline, Embase, Chinese National Knowledge Infrastructure (CNKI), Chinese Scientific Journal (VIP), Wanfang Databases (WANFANG) were searched from inception to June 1, 2023, without language restriction or publication preference. Pooled odds ratio (OR) and 95% confidence interval (CI) for each variable were calculated. Leave-one-out sensitivity analysis was performed to determine the source of heterogeneity. Publication bias was assessed using Begg' and Egger's tests, and the trim-and-fill method was used to compensate for publication bias. The correlation meta-analysis was conducted using Comprehensive Meta-Analysis 3.0 and STATA 12.0 software. All the included studies were based on Asian populations and involved four VDR gene polymorphisms, TaqI (rs731236), ApaI (rs7975232), BsmI (rs1544410) and FokI (rs2228570). The results showed that TaqI (C vs. T: OR = 1.487, 95% CI 1.052, 2.104, P = 0.025; CC + CT vs. TT: OR = 1.830, 95% CI 1.138, 2.944, P = 0.013), ApaI (T vs. G: OR = 1.292, 95% CI 1.101, 1.517, P = 0.002; TT vs. GG: OR = 1.600, 95% CI 1.106, 2.314, P = 0.013; TG vs. GG: OR 1.305, 95% CI 1.050, 1.622; P = 0.016; TT + TG vs. GG: OR = 1.353, 95% CI 1.103, 1.662, P = 0.004), BsmI (GG vs. AA: OR = 1.918, 95% CI 1.293, 2.844, P = 0.001; GA vs. AA: OR = 1.333, 95% CI 1.058, 1.679, P = 0.015; G vs. A: OR = 1.398, 95% CI 1.180, 1.657, P = 0.000; GG vs. AA + GA: OR = 1.686, 95% CI 1.174, 2.423, P = 0.005), and FokI (T vs. C: OR = 1.687, 95% CI 1.474, 1.931, P = 0.000; TT vs. CC: OR = 2.829, 95% CI 2.066, 3.872, P = 0.000; TC vs. CC: OR = 1.579, 95% CI 1.304, 1.913, P = 0.000, TT + TC vs. CC: OR = 1.771, 95% CI 1.477, 2.125, P = 0.000; TT vs. CC + TC: OR = 2.409, 95% CI 1.814, 3.200, P = 0.000) are associated with MM risk. VDR gene polymorphisms including ApaI, BsmI, TaqI, and FokI are associated with MM risk in Asian populations. Additional studies with large sample sizes and different ethnicities are needed.
Identifiants
pubmed: 38833040
doi: 10.1007/s10238-024-01382-4
pii: 10.1007/s10238-024-01382-4
doi:
Substances chimiques
Receptors, Calcitriol
0
VDR protein, human
0
Types de publication
Meta-Analysis
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
118Subventions
Organisme : Natural Science Foundation of Shandong Province
ID : ZR2020KH023
Informations de copyright
© 2024. The Author(s).
Références
Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111(6):2962–72. https://doi.org/10.1182/blood-2007-10-078022 .
doi: 10.1182/blood-2007-10-078022
pubmed: 18332230
pmcid: 2265446
Ismail NH, Mussa A, Al-Khreisat MJ, Yusoff SM, Husin A, Johan MF, et al. The global prevalence of vitamin D deficiency and insufficiency in patients with multiple myeloma: a systematic review and meta-analysis. Nutrients. 2023. https://doi.org/10.3390/nu15143227 .
doi: 10.3390/nu15143227
pubmed: 38068713
pmcid: 10708020
Mirhosseini N, Psihogios A, McLaren MD, Seely D. Vitamin D and multiple myeloma: a scoping review. Curr Oncol. 2023;30(3):3263–76. https://doi.org/10.3390/curroncol30030248 .
doi: 10.3390/curroncol30030248
pubmed: 36975461
pmcid: 10047650
Puthier D, Bataille R, Barille S, Mellerin M-P, Harousseau J-L, Ponzio A, et al. High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study. Support Care Cancer. 2021;30(1):271–8. https://doi.org/10.1007/s00520-021-06414-3 .
doi: 10.1007/s00520-021-06414-3
Wang J, Udd KA, Vidisheva A, Swift RA, Spektor TM, Bravin E, et al. Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. Support Care Cancer. 2016. https://doi.org/10.1007/s00520-016-3126-1 .
doi: 10.1007/s00520-016-3126-1
pubmed: 28039504
pmcid: 5266776
Yellapragada SV, Fillmore NR, Frolov A, Zhou Y, Dev P, Yameen H, et al. Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma. Blood Adv. 2020;4(8):1643–6. https://doi.org/10.1182/bloodadvances.2019001411 .
doi: 10.1182/bloodadvances.2019001411
pubmed: 32315398
pmcid: 7189302
Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, et al. Induction of apoptosis by vitamin D3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase. Br J Haematol. 2000;109(3):576–83. https://doi.org/10.1046/j.1365-2141.2000.02046.x .
doi: 10.1046/j.1365-2141.2000.02046.x
pubmed: 10886207
Park WH, Seol JG, Kim ES, Binderup L, Koeffler HP, Kim BK, et al. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells. Int J Oncol. 2002;20(3):533–42.
pubmed: 11836565
Puthier D, Bataille R, Barille S, Mellerin M-P, Harousseau J-L, Ponzio A, et al. Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone. Blood. 1996;88(12):4659–66. https://doi.org/10.1182/blood.V88.12.4659.bloodjournal88124659 .
doi: 10.1182/blood.V88.12.4659.bloodjournal88124659
pubmed: 8977259
Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, et al. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res. 2000;254(2):279–86. https://doi.org/10.1006/excr.1999.4735 .
doi: 10.1006/excr.1999.4735
pubmed: 10640426
Kumagai T, O’Kelly J, Said JW, Koeffler HP. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst. 2003;95(12):896–905. https://doi.org/10.1093/jnci/95.12.896 .
doi: 10.1093/jnci/95.12.896
pubmed: 12813173
Cavalier E, Makris K, Heijboer AC, Herrmann M, Souberbiellee J-C. Vitamin D: analytical advances, clinical impact, and ongoing debates on health perspectives. Clin Chem. 2024. https://doi.org/10.1093/clinchem/hvae056 .
doi: 10.1093/clinchem/hvae056
pubmed: 38825342
Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010;9(1):66. https://doi.org/10.1186/1475-2891-9-65 .
doi: 10.1186/1475-2891-9-65
Bouillon R, Carmeliet G, Verlinden L, Etten Ev, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726–76. https://doi.org/10.1210/er.2008-0004 .
doi: 10.1210/er.2008-0004
pubmed: 18694980
pmcid: 2583388
Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177(1–2):145–59. https://doi.org/10.1016/s0303-7207(01)00406-3 .
doi: 10.1016/s0303-7207(01)00406-3
pubmed: 11377830
Vaughan-Shaw PG, O’Sullivan F, Farrington SM, Theodoratou E, Campbell H, Dunlop MG, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer. 2017;116(8):1092–110. https://doi.org/10.1038/bjc.2017.44 .
doi: 10.1038/bjc.2017.44
pubmed: 28301870
pmcid: 5396104
Sergentanis TN, Zagouri F, Tsilimidos G, Tsagianni A, Tseliou M, Dimopoulos MA, et al. Risk factors for multiple myeloma: a systematic review of meta-analyses. Clin Lymphoma Myeloma Leuk. 2015;15(10):563-77.e773. https://doi.org/10.1016/j.clml.2015.06.003 .
doi: 10.1016/j.clml.2015.06.003
pubmed: 26294217
Gnagnarella P, Raimondi S, Aristarco V, Johansson H, Bellerba F, Corso F, et al. Ethnicity as modifier of risk for Vitamin D receptors polymorphisms: comprehensive meta-analysis of all cancer sites. Crit Rev Oncol Hematol. 2021;158: 103202. https://doi.org/10.1016/j.critrevonc.2020.103202 .
doi: 10.1016/j.critrevonc.2020.103202
pubmed: 33387627
He Y, Ou C, Pang W, Lin Y, He J, Li C, et al. Genetic association of VDR polymorphisms and multiple myeloma susceptibility: a case control study. Int J Clin Exp Pathol. 2017;10(3):3538–42.
Chen P, Du Z-L, Zhang Y, Liu B, Guo Z, Lou J-X, et al. Association of VEGF and VDR gene–gene and gene-smoking interaction on risk of multiple myeloma in Chinese Han population. Oncotarget. 2017;8(22):36509–16. https://doi.org/10.18632/oncotarget.16510 .
doi: 10.18632/oncotarget.16510
pubmed: 28380424
pmcid: 5482672
Ni Z, Vitamin D. Receptor gene polymorphism and it’s association with multiple myeloma. People’s Hospital of Xinjiang Uygur Autonomous Region. Urumqi: Xinjiang Medical University; 2020.
Kumar R, Himani A, Gupta N, Singh V, Kumar V, Haq A, et al. Unveiling molecular associations of polymorphic variants of VDR gene (FokI, BsmI and ApaI) in multiple myeloma patients of Indian population. J Steroid Biochem Mol Biol. 2020. https://doi.org/10.1016/j.jsbmb.2020.105588 .
doi: 10.1016/j.jsbmb.2020.105588
pubmed: 32004705
Rui H, Liu Y, Lin M, Zheng X. Vitamin D receptor gene polymorphism is associated with multiple myeloma. J Cell Biochem. 2020;121(1):224–30. https://doi.org/10.1002/jcb.29135 .
doi: 10.1002/jcb.29135
pubmed: 31172589
Shafia S, Qasim I, Aziz SA, Bhat IA, Nisar S, Shah ZA. Role of vitamin D receptor (VDR) polymorphisms in susceptibility to multiple myeloma in ethnic Kashmiri population. Blood Cells Mol Dis. 2013;51(1):56–60. https://doi.org/10.1016/j.bcmd.2013.02.001 .
doi: 10.1016/j.bcmd.2013.02.001
pubmed: 23453529
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71 .
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7(1):16. https://doi.org/10.1186/1472-6947-7-16 .
doi: 10.1186/1472-6947-7-16
pubmed: 17573961
pmcid: 1904193
Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis; 2012. Accessed 2012.
Zhang R, Zhang Y, Liu Z, Pei Y, Xu P, Chong W, et al. Association betweeN vitamin D supplementation and cancer mortality: a systematic review and meta-analysis. Cancers. 2022;14(15):66. https://doi.org/10.3390/cancers14153717 .
doi: 10.3390/cancers14153717
Jeon S-M, Shin E-A. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50(4):1–14. https://doi.org/10.1038/s12276-018-0038-9 .
doi: 10.1038/s12276-018-0038-9
pubmed: 30333528
Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367(6460):284–7.
doi: 10.1038/367284a0
pubmed: 8161378
Martelli FS, Mengoni A, Martelli M, Rosati C, Fanti E. VDR TaqI polymorphism is associated with chronic periodontitis in Italian population. Arch Oral Biol. 2011;56(12):1494–8. https://doi.org/10.1016/j.archoralbio.2011.06.012 .
doi: 10.1016/j.archoralbio.2011.06.012
pubmed: 21764034
Castillo-Avila RG, González-Castro TB, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez ML, Rodríguez-Pérez JM, et al. The role of TaqI, ApaI and BsmI polymorphisms of VDR gene in lumbar spine pathologies: systematic review and meta-analysis. Eur Spine J. 2021;30(7):2049–59. https://doi.org/10.1007/s00586-021-06872-7 .
doi: 10.1007/s00586-021-06872-7
pubmed: 34021784
Cong L, Wang W, Liu Q, Du J. FokI polymorphism of the vitamin D receptor gene is associated with susceptibility to gastric cancer: a case–control study. Tohoku J Exp Med. 2015;236(3):219–24. https://doi.org/10.1620/tjem.236.219 .
doi: 10.1620/tjem.236.219
pubmed: 26105695